SCHEMBL5527655

SCHEMBL5527655

O=C1CCOCC1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18124555 0.72
SCHEMBL1565515 0.72
SCHEMBL19337928 0.72
SCHEMBL716179 0.70
SCHEMBL3521660 0.70
SCHEMBL1565514 0.70
SCHEMBL822876 0.70
SCHEMBL12585236 0.70
SCHEMBL17645066 0.70
SCHEMBL198306 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025137507-A1 SOS1 INHIBITORS AND USES THEREOF REGOR PHARMACEUTICALS, INC. (US) 2025-06-26 WO disclosed
WO-2013010453-A1 CHEMOKING RECEPTOR ANTAGONISTS ABBOTT LABORATORIES (US) 2013-01-24 WO disclosed
CN-100467468-C Triaza-spiropiperidine derivatives for use as GLYT-1 inhibitors in the treatment of neurological and neuropsychiatric disorders HOFFMANN LA ROCHE (CH) 2009-03-11 CN disclosed
US-20070276142-A1 Catalytic Asymmetric Synthesis of Optically Active Alpha-Halo-Carbonyl Compounds CHEMINOVA A/S (DK) 2007-11-29 US disclosed
EP-1678177-B1 TRIAZA-SPIROPIPERIDINE DERIVATIVES FOR USE AS GLYT-1 INHIBITORS IN THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS HOFFMANN LA ROCHE (CH) 2007-11-28 EP disclosed
US-7189850-B2 E.g., 1-phenyl-8-(2-phenyl-cyclohexyl)-1,3,8-triaza-spiro[4.5]decan-4-one; activation of N-methylaspartic acid receptors via Glycine (Gly t-1) inhibition; psychoses; analgesics; neurodegenerative and psychological disorders; schizophrenia; cognition activators; antidepressants; Alzheimer's disease HOFFMANN-LA ROCHE INC. (US) 2007-03-13 US disclosed
CN-1922121-A Catalytic asymmetric synthesis of optically active alpha-halo-carbonyl compounds CHEMINOVA AS (DK) 2007-02-28 CN disclosed
CN-1871238-A Triaza-spiropiperidine derivatives for use as GLYT-1 inhibitors in the treatment of neurological and neuropsychiatric disorders HOFFMANN LA ROCHE (CH) 2006-11-29 CN disclosed
EP-1716088-A1 CATALYTIC ASYMMETRIC SYNTHESIS OF OPTICALLY ACTIVE ALPHA-HALO-CAR BONYL COMPOUNDS Cheminova A/S (DK) 2006-11-02 EP disclosed
EP-1678177-A1 TRIAZA-SPIROPIPERIDINE DERIVATIVES FOR USE AS GLYT-1 INHIBITORS IN THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS F.HOFFMANN-LA ROCHE AG (CH) 2006-07-12 EP disclosed
EP-0772610-B9 DIHYDROBENZOFURANES BYK GULDEN LOMBERG CHEM FAB (DE) 2001-07-25 EP disclosed
CN-1068879-C Dihydrobenzofuranes BYK GULDEN LOMBERY CHEM FAB GM (DE) 2001-07-25 CN disclosed
EP-0772610-B1 DIHYDROBENZOFURANES BYK GULDEN LOMBERG CHEM FAB (DE) 2000-10-04 EP disclosed
US-6121274-A PHOSPHODIESTERASE INHIBITOR FOR TREATMENT OF RESPIRATORY SYSTEM DISORDERS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 2000-09-19 US disclosed
US-6054475-A Substituted dihydrobenzofuran-based phosphodiesterase 4 inhibitors useful for treating airway disorders BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 2000-04-25 US disclosed
EP-0941221-A1 SUBSTITUTED DIHYDROBENZOFURANS AS PDE INHIBITORS Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1999-09-15 EP disclosed
WO-1998022453-A1 SUBSTITUTED DIHYDROBENZOFURANS AS PDE INHIBITORS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1998-05-28 WO disclosed
CN-1159804-A Dihydrobenzofuranes BYK GULDEN LOMBERG CHEM FAB (DE) 1997-09-17 CN disclosed
EP-0772610-A1 DIHYDROBENZOFURANES Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1997-05-14 EP disclosed
WO-1996003399-A1 DIHYDROBENZOFURANES BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1996-02-08 WO disclosed